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Objective: To inform pathway design for patients at high risk of an adverse outcome at 5 years 
post-Parkinson’s disease (PD) diagnosis. 
Background: In our service, all newly diagnosed patients follow a 12-month new patient pathway, 
which includes assessment with PDQ-39, NMS Quest and MOCA. Use of a prognostic calculator1 
allows for refinement of the pathway according to patient need. Patients are classified as low 
(0-0.3), medium (0.31-0.79) or high (0.8-1) risk of an adverse outcome at 5 years (postural 
instability, dementia, death). 
Aim: We aim to evaluate whether assessments in the newly diagnosed pathway identify additional 
care needs in higher risk patients. 
Methods: An evaluation was carried out of our new patient database. Individuals who had the 
prognostic indicator performed (n=52) were included in the evaluation. 
Results: Patients in the high risk groups were found to be older and more cognitively impaired than 
lower risk patients (p<.05). MOCA scores negatively correlated with NMS Quest (r=-.44, p<.001) 
and PDQ-39 (r=-.51, p<.001) suggesting as cognition becomes impaired, NMS burden increases, 
and quality of life is reduced. 
Conclusions: Additional care needs were identified in high-risk patients. These findings highlight 
additional resources are required in this patient cohort to ensure needs are met. 
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